Screener
Alkermes ALKS Contingent consideration fair value adjustments
Contingent consideration fair value adjustments at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The source filing: Alkermes’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 9:22 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-319022
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below) | 98,112 | 49,460 | 159,690 | 98,657 |
| Research and development | 112,920 | 77,370 | 216,265 | 149,187 |
| Selling, general and administrative | 217,625 | 170,849 | 482,218 | 342,553 |
| Change in fair value of contingent consideration | 26,414 | — | 26,414 | — |
| Amortization of acquired intangible assets | 22,585 | — | 34,260 | — |
| Total expenses | 477,656 | 297,679 | 918,847 | 590,397 |
| OPERATING (LOSS) INCOME | 18,353 | 92,978 | (29,927) | 106,770 |
| OTHER (EXPENSE) INCOME, NET: |
Item 1. Condensed Consolidated Financial Statements:
FAQ
- What is Alkermes's contingent consideration fair value adjustments?
- Alkermes (ALKS) reported contingent consideration fair value adjustments of $26.41M in Q2 2026.
Ask your AI about Alkermes's contingent consideration fair value adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude